MK0653A (Ezetimibe (+) Simvastatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0653A (Ezetimibe (+) Simvastatin), covering 2024-08-23 to 2024-08-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) [Phase 3]